Westend Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Westend Capital Management's LLY Position: Q3 2026 in Review
Westend Capital Management increased its Eli Lilly (LLY) stake by 0.97% in Q3 2026, buying an estimated $199K and bringing the position to 17,535 shares worth $20.3M. The position accounts for 4.57% of the portfolio, ranked #3.
Westend Capital Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $20.8M in Q2 2026. 4,336 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Westend Capital Management held 17,535 shares of Eli Lilly worth $20.3M as of Q3 2026.
- Westend Capital Management bought 169 Eli Lilly shares in Q3 2026, an estimated $199K.
- Eli Lilly made up 4.57% of Westend Capital Management's portfolio in Q3 2026, its #3 holding.
- Westend Capital Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
- Westend Capital Management's Eli Lilly position peaked at $20.8M in Q2 2026.
- 4,336 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Westend Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.